We are live on ! Find out more
VIVO

Meridian Bioscience Inc
VIVO

Delisted

VIVO was delisted on the 30th of January, 2023.

Back to rankings

2 hedge funds and large institutions have $49K invested in Meridian Bioscience Inc in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 212 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 218 → 2 (-216)

100% less funds holding in top 10

Funds holding in top 10: 7 → 0 (-7)

100% less capital invested

Capital invested by funds: $1.32B → $49K (-$1.32B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 212

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-216
Holders Change %
-99.08%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
212
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$251M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$165M
3
MF
Magnetar Financial
Illinois
-$72.2M
4
Renaissance Technologies
Renaissance Technologies
New York
-$69.8M
5
NAM
Nexpoint Asset Management
Texas
-$64.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
COPPSERS
76
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
– -$1.55M -46,820 Closed
Thrivent Financial for Lutherans
77
Thrivent Financial for Lutherans
Minnesota
– -$1.49M -44,874 Closed
HighTower Advisors
78
HighTower Advisors
Illinois
– -$1.48M -44,515 Closed
HF
79
HRT Financial
New York
– -$1.44M -43,260 Closed
FFH
80
Fairfax Financial Holdings
Ontario, Canada
– -$1.37M -41,400 Closed
MAM
81
Martingale Asset Management
Massachusetts
– -$1.37M -41,387 Closed
Squarepoint
82
Squarepoint
New York
– -$1.3M -39,232 Closed
GH
83
GAM Holding
Switzerland
– -$1.3M -39,200 Closed
PFO
84
Pathstone Family Office
New Jersey
– -$1.28M -38,658 Closed
Jane Street
85
Jane Street
New York
– -$1.23M -37,031 Closed
RWA
86
Redhawk Wealth Advisors
Minnesota
– -$1.22M -36,773 Closed
JMPWA
87
JP Morgan Private Wealth Advisors
California
– -$1.21M -36,397 Closed
CL
88
CSS LLC
Illinois
– -$1.17M -35,200 Closed
LOAMU
89
Lombard Odier Asset Management (USA)
New York
– -$1.16M -35,000 Closed
SDIC
90
South Dakota Investment Council
South Dakota
– -$1.14M -34,363 Closed
HHGC
91
Hunting Hill Global Capital
New York
– -$1.09M -32,795 Closed
YCM
92
Yousif Capital Management
Michigan
– -$1.02M -30,686 Closed
SOADOR
93
State of Alaska Department of Revenue
Alaska
– -$1.01M -30,463 Closed
New York State Common Retirement Fund
94
New York State Common Retirement Fund
New York
– -$1.01M -30,400 Closed
Wellington Management Group
95
Wellington Management Group
Massachusetts
– -$1M -30,221 Closed
BBA
96
Baader Bank Aktiengesellschaft
Germany
– -$996K -30,000 Closed
PCM
97
Pentwater Capital Management
Florida
– -$996K -30,000 Closed
TPSF
98
Texas Permanent School Fund
Texas
– -$977K -29,411 Closed
SG Americas Securities
99
SG Americas Securities
New York
– -$912K -27,466 Closed
T. Rowe Price Associates
100
T. Rowe Price Associates
Maryland
– -$904K -27,215 Closed
2 3
4
5 6

VIVO Hedge Fund Activity: Q1 2023 in Review

2 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q1 2023, worth a combined $49K — down 100% from $1.32B a quarter earlier.

Sellers outnumbered buyers: 212 funds closed out of VIVO and 0 opened new positions — a net loss of 212 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $251M sold.

  • 2 institutional investors held Meridian Bioscience Inc (VIVO) as of Q1 2023, down from 218 in Q4 2022.
  • Funds reported $49K of Meridian Bioscience Inc stock for Q1 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Meridian Bioscience Inc positions in Q1 2023 and 212 closed out, a net change of -212 holders.
  • The largest Meridian Bioscience Inc seller in Q1 2023 was BlackRock, an estimated $251M sold.

Based on aggregated 13F filings for Q1 2023.